Department of Neuroscience, Section of Forensic Medicine, University of Pisa, Via Roma 57, Pisa 56126, Italy.
J Anal Toxicol. 2011 May;35(4):193-8. doi: 10.1093/anatox/35.4.193.
The present work describes the validation of a novel aqueous in situ derivatization procedure with trimethyloxonium tetrafluoroborate (TMO) as methylating agent for the simultaneous, quantitative analysis of Δ(9)-tetrahydrocannabinol (THC) and 11-nor-Δ(9)-tetrahydrocannabinol carboxylic acid (THC-COOH) in human urine. The derivatizing agent is directly added to the urine sample and the methyl-derivatives are then recovered by liquid-liquid extraction procedure. Gas chromatography-mass spectrometry was used to detect the derivatives in selected ion monitoring mode. The limits of detection were 0.7 ng/mL for THC and 0.5 ng/mL for THC-COOH, whereas the limits of quantification were 1.9 and 0.9 ng/mL, respectively. The method has been applied to 60 real samples both positive and negative to immunochemical screening test resulting to be very useful and reliable in routine analysis of THC-COOH in human urine for toxicological and forensic purposes.
本工作描述了一种新型的水相原位衍生化方法,使用三甲基氧𬭩四氟硼酸盐(TMO)作为甲基化剂,可同时定量分析尿液中的 Δ(9)-四氢大麻酚(THC)和 11-去甲-Δ(9)-四氢大麻酚羧酸(THC-COOH)。衍生化剂直接加入尿液样品中,然后通过液液萃取程序回收甲基衍生物。采用气相色谱-质谱联用仪在选择离子监测模式下检测衍生物。THC 的检测限为 0.7 ng/mL,THC-COOH 的检测限为 0.5 ng/mL,定量限分别为 1.9 和 0.9 ng/mL。该方法已应用于 60 份经免疫化学筛选试验确证为阳性和阴性的实际样品,对于毒理学和法医学目的的尿液中 THC-COOH 的常规分析非常有用和可靠。